John V. Umstead G1 Therapeutics, Inc. (GTHX) insider trading activity
John V. Umstead is Chief Financial Officer of G1 Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GTHX, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2024, when has been sold 19,331 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
100.0%
12M change
Total Value Held
$0
John V. Umstead Transaction History
JVU
John V. Umstead
Chief Financial Officer
Research Triangle Park, NC